← All trials
NCT06028672
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 12, 2023
- Primary completion
- Aug 31, 2025
- Completion date
- Aug 31, 2025
- First posted
- Sep 8, 2023
- Last posted
- Oct 10, 2023
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chinese Academy of Medical SciencesLead sponsor
- Shanghai Junshi Bioscience Co.,Ltd.Collaborator
- Shengjing HospitalCollaborator
- Fudan UniversityCollaborator
- Xiamen UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- Henan Medical UniversityCollaborator
- University of Electronic Science and Technology of ChinaCollaborator
- Chinese Academy of Medical SciencesReponsible party - principal investigator
- Gansu Provincial Maternity and Child-Care HospitalCollaborator
- Dalian Maternity and Child Care HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.